pages:
-
A prospective, randomized, double blind, placebo-controlled, multicenter, Phase 2b study of OTO-104 given as a single intratympanic injection in subjects with unilateral Menieres disease (104-201102)
-
A Prospective, Randomized, Double-Blind, Sham- Controlled, Multi-Center Pivotal Study to Evaluate the Efficacy and Safety of Duodenal Mucosal Resurfacing Using the Revita® System in Subjects with Type 2
Diabetes on Insulin therapy
-
A prospective, single arm, multi-center clinical study to evaluate the thoracotomy implant technique(Heartware 006)
-
A prospective, single-center, randomized, double masked, sham controlled study to evaluate the safety, efficacy and tolerability of OTX-TI (sustained release travoprost) Intracameral Depot compared to topical travoprost in subjects with OA & OHT.
Research Grant
-
A Prospective, Two-Stage, Non-randomized, Multi-center Within Patient Comparison Study to Evaluate the SENSE Device's Ability to Monitor Intracranial Hemorrhage
-
A Psycholinguistic Study of the Processing Japanese Sentences by Native Speakers
Research Grant
-
A psychological exploration into factors reducing bias in helping behaviors among religious people
Research Grant
-
A Qualitative Study to Identify Meaningful Communication Strategies for Delivering Antimicrobial Stewardship Recommendations and Decisions in U.S. Hospitals
Research Grant
-
A Quality Improvement Approach to the Management of CLL--Research
Research Grant
-
A quantitative and qualitative analysis of adherence to oral anti-cancer therapeutics in the gynecology oncology population
Fellowships, Supported Research, and Other Grants
-
A Quantitative and Qualitative Exploration of Distress Symptoms in Lung Cancer
Fellowships, Supported Research, and Other Grants
-
A Quantitative Optical Sensor to Monitor Tumor Vascular Physiology
Research Grant
-
A Randomised, Controlled, Phase 3 Study of the Safety and Efficacy of Intracerebral Stem Cells (CTX0E03 DP) in Patients with Disability Following an Ischaemic Stroke
-
A Randomized Controlled Multidose Multicentre Adaptive Phase II/III Study in Infants with Proliferating Infantile Hemangiomas Requiring Systemic Therapy to Compare Four Regimens of Propanolol (1 or 3 mg/kg/day for 3 to 6 months) to Placebo (Double-Blind)
Fellowships, Supported Research, and Other Grants
-
A Randomized Controlled Trial of Immediate versus Delayed Postpartum Implanon®: A Pilot Study
Fellowships, Supported Research, and Other Grants
-
A randomized controlled trial of rivaroxaban for the prevent of major cardiovascular events in patients with coronaryor periphery artery disease (COMPASS - Cardiovascular OutcoMes for People using Anticoagulation)
-
A Randomized Double Blind Placebo Controlled Single Dose, Two Period Crossover Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinic Efficacy of AMG 811 in Subjects with Discoid Lupus Erythematosus
Fellowships, Supported Research, and Other Grants
-
A randomized double blind studyh of Ruxolitinib or placebo in combination with Regorafenib in subjects with relapsed or refractory metastatic colorectal cancer.
-
A randomized double blinded placebo controlled phase III study of adjuvant Regorafenib versus placebo for patient with stage IV coloractal cancer after curative treatment of liver metastases.
-
A randomized double bline phase 3 study of the JAK 1/2 inhibitor Ruxotinib or placebo in conbination with capecitbine in subjects with advanced or metastatic adenocarcinoma of the pancreas
-
A Randomized Double-Blind Placebo-Controlled Study to Evaluate the
Efficacy and Safety of Volixibat in the Treatment of Cholestatic
Pruritus in Patients with Primary Sclerosing Cholangitis (VISTAS)
-
A randomized double-blind trial on the safety and immunogenicity of inactivated trivalent influenza vaccine in pregnant women.
Research Grant
-
A Randomized Double-Blind, Phase 3 Study Comparing the Efficacy and Safety of High-Titer versus Low-Titer Anti-Influenza Immune Plasma for the Treatment of Severe Influenza A; IRC-005
-
A Randomized multicenter double blind Phase III study of Nivolumab or placebo in subjects with resected esophageal junction cancer.
-
A Randomized Multicenter Phase 3 Study of Milademetan Versus Trabectedin in Patients with Dedifferentiated Liposarcoma
-
A randomized multicenter Phase II trial to evaluate the safety, efficacy and immunogenicity of
vaccination with Folate Receptor Alpha peptides admixed with GM-CSF as a vaccine adjuvant
Research Grant
-
A Randomized Multicenter Pivotal Study of CDX-011 (CR011-vcMMAE) in Patients with Metastatic, GPNMB Over-Expressing, Triple-Negative Breast Cancer (CDX011-04)
Research Grant
-
A Randomized Open Label Phase 2 Study of Denintuzumab mafodotin (SGN -CD19A)
-
A randomized open-label trial of deprescribing proton pump inhibitors to reduce the risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation
Research Grant
-
A Randomized Open-Label, Multi-Center Pivotal Study of ANG1005 Compared with Physician's Best Choice in HER2-Negative Breast Cancer Patients with Newly Diagnosed Leptomeningeal Carcinomatosis and Previously Treated Brain Metastases (ANGLeD)
pages: